Macrogenics Inc (MGNX): Cash & Equivalents
$57.22M
As of 2025-12-31
$113.91M
As of 2026-06-30
-19.3%
3-year compound annual growth
-20.6%
5-year compound annual growth
-11.6%
10-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $57.22M | -68.7% | 2026-03-09, Balance as of period end |
| 2024-12-31 | $182.84M | +81.1% | 2026-03-09, Balance as of period end |
| 2023-12-31 | $100.96M | -7.3% | 2025-03-20, Balance as of period end |
| 2022-12-31 | $108.88M | -11.8% | 2024-03-07, Balance as of period end |
| 2021-12-31 | $123.47M | -31.8% | 2023-03-15, Balance as of period end |
| 2020-12-31 | $181.13M | +43.2% | 2022-02-24, Balance as of period end |
| 2019-12-31 | $126.47M | -42.5% | 2021-02-25, Balance as of period end |
| 2018-12-31 | $220.13M | +4.0% | 2020-02-25, Balance as of period end |
| 2017-12-31 | $211.73M | +151.8% | 2019-02-26, Balance as of period end |
| 2016-12-31 | $84.10M | -57.1% | 2019-02-26, Balance as of period end |
| 2015-12-31 | $196.17M | +24.5% | 2018-02-27, Balance as of period end |
| 2014-12-31 | $157.59M | +35.3% | 2017-02-28, Balance as of period end |
| 2013-12-31 | $116.48M | +144.0% | 2016-02-29, Balance as of period end |
| 2012-12-31 | $47.74M | -13.5% | 2015-03-03, Balance as of period end |
| 2011-12-31 | $55.22M | n/a | 2014-03-20, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| Macrogenics Inc (MGNX) | 2025-12-31 | $57.22M | -68.7% |
| Karyopharm Therapeutics Inc. (KPTI) | 2025-12-31 | $60.54M | -3.1% |
| Heron Therapeutics, Inc. (HRTX) | 2025-12-31 | $28.65M | +11.0% |
| Liquidia Corp (LQDA) | 2025-12-31 | $190.68M | +8.0% |
| Syndax Pharmaceuticals Inc (SNDX) | 2025-12-31 | $134.93M | -12.4% |
| Lifecore Biomedical, Inc. (LFCR) | 2025-05-25 | $8.27M | -2.3% |
| Phathom Pharmaceuticals, Inc. (PHAT) | 2025-12-31 | $129.97M | -56.3% |
| Cryoport, Inc. (CYRX) | 2025-12-31 | $250.49M | +633.8% |
| Xencor Inc (XNCR) | 2025-12-31 | $54.07M | +32.3% |
Compare MGNX, KPTI, HRTX, LQDA side by side · Screen every company in Pharmaceutical Preparations ↗